LV

Lifespan Vision Ventures

North America, Connecticut, United States, Norwalk

Description

Lifespan Vision Ventures invests in companies that develop therapeutics focusing on longevity and aging reversal.

Investor Profile

Lifespan Vision Ventures has backed more than 9 startups, with 4 new investments in the last 12 months alone. The firm has led 5 rounds, about 56% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series Unknown, Series A rounds (top funding stages).
  • Majority of deals are located in United States, United Kingdom.
  • Strong thematic focus on Biotechnology, Health Care, Life Science.
  • Led 1 rounds in the past year.

Stage Focus

  • Seed (44%)
  • Series Unknown (33%)
  • Series A (11%)
  • Convertible Note (11%)

Country Focus

  • United States (78%)
  • United Kingdom (22%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Therapeutics
  • Biopharma
  • Medical
  • Nanotechnology
  • Oncology
  • Pharmaceutical
  • Machine Learning
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Lifespan Vision Ventures frequently co-invest with?

Conscience VC
North America, Texas, United States, Austin
Co-Investments: 1
Emerging Longevity Ventures
North America, Florida, United States, West Palm Beach
Co-Investments: 1
Starbloom Capital
North America, Texas, United States, Houston
Co-Investments: 1
TI
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Civilization Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Q
North America, Massachusetts, United States, Boston
Co-Investments: 1
QantX
Europe, Devon, United Kingdom, Exeter
Co-Investments: 1
APEX Ventures
Europe, Wien, Austria, Vienna
Co-Investments: 1
R42 Group
North America, California, United States, Stanford
Co-Investments: 1

Which angels does Lifespan Vision Ventures often collaborate with?

SH
North America, New York, United States, New York
Shared Deals: 1
MS
North America, California, United States, Santa Monica
Shared Deals: 1
VP
North America, New York, United States, New York
Shared Deals: 1
JM
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by Lifespan Vision Ventures?

EpiBone

Jersey City, New Jersey, United States

EpiBone is a bone reconstruction company that advances skeletal reconstruction through 3D design and living cells.

3D TechnologyBiotechnologyHealth CareMedical
Convertible NoteNov 8, 2024
Integrated Biosciences

Redwood City, California, United States

Integrated Biosciences develops next-generation therapeutics.

BiopharmaBiotechnologyLife ScienceMachine LearningTherapeutics
SeedOct 3, 2024
Amount Raised: $17,200,000
LIfT BioSciences

London, England, United Kingdom

LIfT Biosciences® a rapidly emerging biotech company bringing to market a first-in-class allogeneic innate cell therapy

BiopharmaBiotechnologyHealth CareLife ScienceMedicalOncologyPharmaceutical
Series ASep 24, 2024
Amount Raised: $13,426,856
Remedium Bio

Needham, Massachusetts, United States

Remedium Bio is a gene therapy company focused on the development of highly innovative treatments for a broad range of diseases.

BiotechnologyHealth CareTherapeutics
SeedSep 10, 2024
Senisca

Exeter, Devon, United Kingdom

Senisca is a biotech spinout company that creates a new generation of oligonucleotide-based interventions.

BiotechnologyHealth Care
SeedMar 18, 2024
Amount Raised: $4,708,943
Bolden Therapeutics

Providence, Rhode Island, United States

Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases.

BiotechnologyTherapeutics
Series UnknownJan 9, 2024
NaNotics

Mill Valley, California, United States

NaNotics is developing an advanced nanomedical platform for treating major diseases in humans and their companion animals.

BiotechnologyHealth CareNanotechnology
Series UnknownOct 30, 2023
Matter Bio

New York, New York, United States

Matter Bio operates as company focus on preserving genome integrity.

BiotechnologyLife Science
SeedOct 23, 2023
Amount Raised: $7,000,000
Rejuvenation Technologies

Mountain View, California, United States

Rejuvenation Technologies is a biotechnology company that developed nucleoside-modified TERT mRNA to safely and rapidly extend telomeres.

BiotechnologyHealth Care
Series UnknownOct 11, 2023